Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage

References

• World Health Organization. Recommendations for the Prevention of Postpartum Haemorrhage. Geneva: WHO, 2007.
   Google Scholar
• Leduc D, Senikas V, Lalonde AB, Ballerman C, Biringer A, Delaney M, Duperron L, et al. SOGC Clinical Practice Guidelines. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. No. 235 October 2009 (Replaces No. 88, April 2000). Int J Gynecol Obstet 2010;108:258–267.
   PubMedGoogle Scholar
• Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008;22:999–1012.
   PubMed Web of Science ®Google Scholar
• Oladapo OT, Akinola OI, Fawole AO, Adeyemi AS, Adegbola O, Loto OM, Fabamwo AO, et al. Nigerian AMTSL Group. Active management of third stage of labor: evidence versus practice. Acta Obstet Gynecol Scand 2009;88:1252–1260.
   PubMed Web of Science ®Google Scholar
• Homer C, Clements V, McDonnell N, Peek M, Sullivan E. Maternal mortality: what can we learn from stories of postpartum haemorrhage? Women Birth 2009;22:97–104.
   PubMedGoogle Scholar
• Chong YS, Su LL, Arulkumaran S. Current strategies for the prevention of postpartum haemorrhage in the third stage of labour. Curr Opin Obstet Gynecol 2004;16:143–150.
   PubMed Web of Science ®Google Scholar
• Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin to prevent haemorrhage at caesarean section–a survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol 2008;137:27–30.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician–Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006;108:1039–1047.
   PubMedGoogle Scholar
• Begley CM, Gyte GM, Murphy DJ, Devane D, McDonald SJ, McGuire W. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev 2010;7:CD007412.
   Google Scholar
• Borruto F, Treisser A, Comparetto C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch Gynecol Obstet 2009;280:707–712.
   PubMed Web of Science ®Google Scholar
• Mousa HA, Cording V, Alfirevic Z. Risk factors and interventions associated with major primary postpartum hemorrhage unresponsive to first-line conventional therapy. Acta Obstet Gynecol Scand 2008;87:652–661.
   PubMed Web of Science ®Google Scholar
• Rath W. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. Eur J Obstet Gynecol Reprod Biol 2009;147:15–20.
   PubMed Web of Science ®Google Scholar
• Boucher M, Nimrod CA, Tawagi GF, Meeker TA, Rennicks White RE, Varin J. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery: a double-blind randomized trial. J Obstet Gynaecol Can 2004;26:481–488.
   PubMedGoogle Scholar
• Leung SW, Ng PS, Wong WY, Cheung TH. A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour. BJOG 2006;113:1459–1464.
   PubMed Web of Science ®Google Scholar
• Ngan L, Keong W, Martins R. Carbetocin versus a combination of oxytocin and ergometrine in control of postpartum blood loss. Int J Gynaecol Obstet 2007;97:152–153.
   PubMedGoogle Scholar
• Su LL, Chong YS, Samuel M. Oxytocin agonists for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2000.
   Google Scholar
• Atke A, Vilhardt H. Uterotonic activity and myometrial receptor affinity of Ideamino-l-carba-2-tyrosine (O-methyl)-oxytocin. Acta Endocrinol (Copenh) 1987;19:971–976.
   Google Scholar
• Norström A, Andersson A, Vilhardt H. Contractile effect of oxytocin and Ideamino-l-carba-2-tyrosine (O-methyl)-oxytocin in myometrial tissue from non-pregnant and term pregnant women. Acta Endocrinol (Copenh) 1990;122:566–568.
   PubMedGoogle Scholar
• Engstrøm T, Barth T, Melin P, Vilhardt H. Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation. Eur J Pharmacol 1998;355:203–210.
   PubMed Web of Science ®Google Scholar
• Weis FR Jr, Markello R, Mo B, Bochiechio P. Cardiovascular effects of oxytocin. Obstet Gynecol 1975;46:211–214.
   PubMedGoogle Scholar
• Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing caesarean section. Br J Anaesth 2007;98:116–119.
   PubMed Web of Science ®Google Scholar
• Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, Hunt LP, Draycott T. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG 2010;117:929–936.
   PubMed Web of Science ®Google Scholar
• Dansereau J, Joshi AK, Helewa ME, Doran TA, Lange IR, Luther ER, Farine D, et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol 1999;180:670–676.
   PubMed Web of Science ®Google Scholar
• Boucher M, Horbay GL, Griffin P, Deschamps Y, Desjardins C, Schulz M, Wassenaar W. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section. J Perinatol 1998;18:202–207.
   PubMedGoogle Scholar
• Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther 1992;52:60–67.
   PubMed Web of Science ®Google Scholar
• Vercauteren M, Palit S, Soetens F, Jacquemyn Y, Alahuhta S. Anaesthesiological considerations on tocolytic and uterotonic therapy in obstetrics. Acta Anaesthesiol Scand 2009;53:701–709.
   PubMed Web of Science ®Google Scholar